Northstar Neuroscience Says It Has The Cash To Overcome EVEREST Setback

Northstar Neuroscience says it has enough cash reserves to continue developing its cortical stimulation technology for tinnitus and depression, despite the disappointing results of the first pivotal trial for a stroke indication